Diabetes Board decisions

The Board remands the claim for service connection for diabetes mellitus, type II, to include as due to in-service exposure to contaminated water at Camp Lejeune and/or as secondary to service-connected prostate cancer for further development.

The Board remands the claims for service connection for prostate cancer, NHL, hypothyroidism, DM II, and an acquired psychiatric disorder to correct a duty to assist error that occurred prior to the October 2024 rating decision.

The Board denied the Veteran's claim for special monthly compensation (SMC) based on aid and attendance, finding that he does not meet the criteria due to his service-connected disabilities.

The Veteran withdrew his appeal for service connection for erectile dysfunction, prostate cancer, hearing loss, tinnitus, diabetes mellitus, PTSD, sleep apnea, and vision loss.

The Board remands the Veteran's claim for service connection for diabetes mellitus type II to correct a pre-decisional duty-to-assist error.

The Board denied earlier effective dates for service connection and ratings for various diabetic conditions, as the earliest possible date under the PACT Act was August 10, 2022.

The Board remands the claim for service connection of diabetes type II to schedule a VA examination and obtain an adequate TERA evaluation.

The Board denied service connection for erectile dysfunction, diabetes mellitus, type II, and a higher initial disability rating for a scalp scar due to insufficient evidence linking these conditions to the Veteran's active service.

The Board remands the claims for service connection for chronic kidney disease stage 4, diabetes mellitus type II, and hypertension to obtain an addendum opinion regarding their relationship to toxic exposure during military service.

The appeal for increased ratings was dismissed due to lack of jurisdiction, and the claim for service connection for type II diabetes mellitus (DM) is remanded for further development.

The Board remands the veteran's claims for service connection for various disabilities, including eye disability, supraventricular arrhythmias, diabetes mellitus, type II, hypertension, chronic kidney disease, back pain, and knee pain, to correct duty-to-assist errors.

The Board remands the claims for service connection for gout, sleep apnea, diabetes mellitus, a headache disorder, and hypertension to correct a duty to assist error.

The Board remands the claims for service connection due to a duty to assist error that occurred prior to the respective rating decisions on appeal.

The Board granted service connection for diabetes mellitus type II as secondary to posttraumatic stress disorder with unspecified insomnia disorder and other service-connected disabilities, an effective date of March 8, 2022, for tinnitus, denied an earlier effective date prior to January 30, 2020, for sleep apnea, and granted a 30 percent rating for pseudofolliculitis barbae, effective August 27, 2019.

The Board denied the veteran's claims for service connection for diabetes mellitus type II, a lower back disability, a left shoulder disability, and a right shoulder disability as there was no evidence of an in-service injury or disease, and no evidence linking these conditions to his active military service.

The Board remands the case for an aid and attendance examination to assess the Veteran's functional impairment due to his service-connected disabilities.

The Board granted service connection for a psychiatric disability, identified as generalized anxiety disorder and depression. The claims for lead poisoning, substance abuse disorder, diabetes mellitus, hepatitis C, and hypertension were remanded.

The Board denied service connection for diabetes mellitus, finding no current diagnosis of the condition. The claim for hypertension was remanded due to insufficient evidence linking it to service.

The Board granted service connection for bilateral hearing loss, tinnitus, and diabetes mellitus, type II, based on in-service noise exposure and herbicide exposure, respectively.

The Board denied an initial compensable evaluation higher than 20 percent for diabetes mellitus type II and remanded the claim for service connection for hypertension associated with herbicide exposure.